Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-014408
Filing Date
2021-06-15
Accepted
2021-06-15 16:23:37
Documents
38
Period of Report
2021-01-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 529866
2 ex31-1.htm EX-31.1 29368
3 ex32-1.htm EX-32.1 14534
4 logo_002.jpg GRAPHIC 8602
  Complete submission text file 0001493152-21-014408.txt   1771262

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE bqst-20210131.xml EX-101.INS 160217
6 XBRL SCHEMA FILE bqst-20210131.xsd EX-101.SCH 20387
7 XBRL CALCULATION FILE bqst-20210131_cal.xml EX-101.CAL 26299
8 XBRL DEFINITION FILE bqst-20210131_def.xml EX-101.DEF 67168
9 XBRL LABEL FILE bqst-20210131_lab.xml EX-101.LAB 143595
10 XBRL PRESENTATION FILE bqst-20210131_pre.xml EX-101.PRE 111838
Mailing Address 4570 CAMPUS DRIVE #23 NEWPORT BEACH NEWPORT BEACH CA 92660
Business Address 4570 CAMPUS DRIVE #23 NEWPORT BEACH NEWPORT BEACH CA 92660 418-264-7134
Bioquest Corp (Filer) CIK: 0001568628 (see all company filings)

EIN.: 990378854 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 000-56260 | Film No.: 211018803
SIC: 2834 Pharmaceutical Preparations